A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients (NCT07556861) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients
United States40 participantsStarted 2026-05-16
Plain-language summary
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type
* Alcohol use disorder.
* Ability to read, write, and understand English;
* Minimum DAST (1+) or AUDIT-C score (3+)
* Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care;
* Eligibility determined by ASAM Assessment
Exclusion Criteria:
* Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis;
* Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment;
* Needing a higher level of mental health care as demonstrated by ASAM\[36\] assessment;
* Decline to answer suicidality questions;
* Already admitted into or about to initiate treatment in another addiction treatment program.
* Currently attending High School.
* Pregnancy confirmed by self-report